These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 27117922)

  • 21. Prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix.
    Huang EY; Hsu HC; Sun LM; Chanchien CC; Lin H; Chen HC; Tseng CW; Ou YC; Chang HY; Fang FM; Huang YJ; Wang CY; Lu HM; Tsai CC; Ma YY; Fu HC; Wang YM; Wang CJ
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1105-13. PubMed ID: 20932670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) and serum squamous cell carcinoma antigen (SCC-ag) function as prognostic biomarkers in patients with primary cervical cancer.
    Pan L; Cheng J; Zhou M; Yao Z; Zhang Y
    J Cancer Res Clin Oncol; 2012 Feb; 138(2):239-46. PubMed ID: 22102174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation Between Squamous Cell Carcinoma Antigen Level and the Clinicopathological Features of Early-Stage Cervical Squamous Cell Carcinoma and the Predictive Value of Squamous Cell Carcinoma Antigen Combined With Computed Tomography Scan for Lymph Node Metastasis.
    Xu D; Wang D; Wang S; Tian Y; Long Z; Ren X
    Int J Gynecol Cancer; 2017 Nov; 27(9):1935-1942. PubMed ID: 28914639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated circulating tumor cells and squamous cell carcinoma antigen levels predict poor survival for patients with locally advanced cervical cancer treated with radiotherapy.
    Wen YF; Cheng TT; Chen XL; Huang WJ; Peng HH; Zhou TC; Lin XD; Zeng LS
    PLoS One; 2018; 13(10):e0204334. PubMed ID: 30303986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of pretreatment squamous cell carcinoma antigen level in locally advanced squamous cell carcinoma of the uterine cervix treated by radiotherapy.
    Ogino I; Nakayama H; Okamoto N; Kitamura T; Inoue T
    Int J Gynecol Cancer; 2006; 16(3):1094-100. PubMed ID: 16803491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of serum squamous cell carcinoma antigen for follow-up monitoring of cervical cancer patients who were treated by concurrent chemoradiotherapy.
    Yoon SM; Shin KH; Kim JY; Seo SS; Park SY; Moon SH; Cho KH
    Radiat Oncol; 2010 Sep; 5():78. PubMed ID: 20840788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive value of preoperative serum squamous cell carcinoma antigen level for lymph node metastasis in early-stage cervical squamous cell carcinoma.
    Zhu C; Zhang W; Wang X; Jiao L; Chen L; Jiang J
    Medicine (Baltimore); 2021 Aug; 100(33):e26960. PubMed ID: 34414964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SCC-Ag, lymph node metastases and sentinel node procedure in early stage squamous cell cervical cancer.
    van de Lande J; Davelaar EM; von Mensdorff-Pouilly S; Water TJ; Berkhof J; van Baal WM; Kenemans P; Verheijen RH
    Gynecol Oncol; 2009 Jan; 112(1):119-25. PubMed ID: 19007978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum concentrations of squamous-cell carcinoma antigen and tissue polypeptide antigen in the follow-up of patients with vulvar cancer.
    Hefler L; Frischmuth K; Heinze G; Sliutz G; Leodolter S; Reinthaller A; Kainz C; Tempfer C
    Int J Cancer; 1999 Oct; 83(2):167-70. PubMed ID: 10471522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pretreatment serum CYFRA 21-1 level correlates significantly with survival of cervical cancer patients: a multivariate analysis of 506 cases.
    Piao X; Kong TW; Chang SJ; Paek J; Chun M; Ryu HS
    Gynecol Oncol; 2015 Jul; 138(1):89-93. PubMed ID: 25913134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of pretreatment SUV
    Shou H; Yasuo Y; Yuan S; Lou H; Ni J
    Int J Gynaecol Obstet; 2021 Jan; 152(1):112-117. PubMed ID: 33141954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical values of squamous cell carcinoma antigen and carcinoembryonic antigen in patients with cervical cancer treated with concurrent chemoradiotherapy.
    Yoon SM; Shin KH; Kim JY; Seo SS; Park SY; Kang S; Cho KH
    Int J Gynecol Cancer; 2007; 17(4):872-8. PubMed ID: 17343571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical value of serum biomarkers, squamous cell carcinoma antigen and apolipoprotein C-II in follow-up of patients with locally advanced cervical squamous cell carcinoma treated with radiation: A multicenter prospective cohort study.
    Harima Y; Ariga T; Kaneyasu Y; Ikushima H; Tokumaru S; Shimamoto S; Takahashi T; Ii N; Tsujino K; Saito AI; Ushijima H; Toita T; Ohno T
    PLoS One; 2021; 16(11):e0259235. PubMed ID: 34727105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The kinetic profile and clinical implication of SCC-Ag in squamous cervical cancer patients undergoing radical hysterectomy using the Simoa assay: a prospective observational study.
    Ye S; Sun X; Kang B; Wu F; Zheng Z; Xiang L; Lesénéchal M; Heskia F; Liang J; Yang H
    BMC Cancer; 2020 Feb; 20(1):138. PubMed ID: 32085736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Squamous cell carcinoma antigen and cancer antigen 125 in southern Indian cervical cancer patients.
    Porika M; Vemunoori AK; Tippani R; Mohammad A; Bollam SR; Abbagani S
    Asian Pac J Cancer Prev; 2010; 11(6):1745-7. PubMed ID: 21338226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positron emission tomography for unexplained elevation of serum squamous cell carcinoma antigen levels during follow-up for patients with cervical malignancies: a phase II study.
    Chang TC; Law KS; Hong JH; Lai CH; Ng KK; Hsueh S; See LC; Chang YC; Tsai CS; Chou HH; Huang KG; Liou JD; Lin CT; Chao A; Chen MY; Wu TI; Ma SY; Yen TC
    Cancer; 2004 Jul; 101(1):164-71. PubMed ID: 15222002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time-Dependent Squamous Cell Carcinoma Antigen in Prediction of Relapse and Death of Patients With Cervical Cancer.
    Chang C; Chen J; Huang CH; Lee WY; Hsu LC; Chiang AJ
    J Low Genit Tract Dis; 2020 Jan; 24(1):38-42. PubMed ID: 31860573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Application of 18F-FDG PET/CT in cervical cancer with elevated levels of serum squamous cell carcinoma antigen during the follow-up].
    Hu YY; Sun XR; Lin XP; Liang PY; Zhang X; Fan W
    Ai Zheng; 2009 Sep; 28(9):994-9. PubMed ID: 19728921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Significance of Serum SCC Levels Before Treatment for Locally Advanced Cervical Squamous Cell Carcinoma.
    Yamaoka Y; Tamura S; Yamanoi K; Taki M; Murakami R; Yamaguchi K; Hamanishi J; Mandai M
    Anticancer Res; 2024 May; 44(5):2009-2019. PubMed ID: 38677756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of post-radiation serum squamous cell carcinoma antigen and primary tumor regression for cervical squamous cell carcinoma.
    Wan Q; Yan W; Liu Y; Lin Y; Lu Z
    Cancer Biomark; 2020; 29(3):327-335. PubMed ID: 32716344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.